James Nagarajah

14PUBLICATIONS
45CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Nuclear engineering (incl. fuel enrichment and waste processing and storage)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 21, 2024
Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer.

Bastiaan M Privé, Bas Israël, Marcel J R Janssen

|Jan 08, 2023
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.

Amina Banda, Bastiaan M Privé, Youssra Allach

|May 20, 2022
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study.

Manuel Weber, David Kersting, Burkhard Riemann

Pageof 3